Citigroup’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $38K | Sell |
|
|||||
|
2021
Q4 | $123K | Sell |
|
|||||
|
2021
Q3 | $186K | Sell |
|
|||||
|
2021
Q2 | $308K | Buy |
|
|||||
|
2021
Q1 | $238K | Buy |
|
|||||
|
2020
Q4 | $248K | Sell |
|
|||||
|
2020
Q3 | $241K | Buy |
|
|||||
|
2020
Q2 | $240K | Sell |
|
|||||
|
2020
Q1 | $208K | Sell |
|
|||||
|
2019
Q4 | $299K | Buy |
|
|||||
|
2019
Q3 | $206K | Sell |
|
|||||
|
2019
Q2 | $242K | Buy |
|
|||||
|
2019
Q1 | $159K | Buy |
|
|||||
|
2018
Q4 | $136K | Buy |
|
|||||
|
2018
Q3 | $154K | Sell |
|
|||||
|
2018
Q2 | $169K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $24K | Buy |
|